Salicylate
From Anvita Health Wiki
Contents |
More Specific Terms
- 5-aminosalicylate (5-ASA)
- aspirin (Ecotrin, Empirin, Bayer aspirin, ASA)
- choline salicylate
- magnesium salicylate
- methyl salicylate
- para-aminosalicylate; PAS; 4-aminosalicylate (Pamisyl, Paser)
- phenyl salicylate
- salicylic acid
- salsalate (Salflex, Disalcid, sasapyrine)
- thiosalicylate
Introduction
- ortho-hydroxybenzoate.
Dosage
- estimated lethal dose is 15 g
Pharmacokinetics
- major hydrolysis product of aspirin
- major hydrolysis product of aspirin
- 1/2life = 2.4-3.0 hours
- protein binding = 90-95 % < 100 ug/mL
- protein binding = 50 % 400 ug/mL
Adverse-effects
- tinnitius, inhibits outer hair cell motility
- stomach upset
- leukopenia (uncommon)
- thrombocytopenia (uncommon)
- drug adverse effects of NSAIDs
Laboratory
-
- interferences:
- colorimetric & fluorometric assays subject to multiple interference; however, they are fast & useful for emergency overdose assessment
- diflusinal interferes with FPIA & color methods
- lipemic, icteric, or hemolyzed specimens may give false positive results with color method
Mechanism-of-action
- non- acetylated salicylates are
- more potent inhibitors of cyclo- oxygenase-2 ( COX-2) than COX-1
- they differ from aspirin & NSAIDs with regards to
- diminished propensity to induce peptic ulcer disease
- no interference with renal blood flow
- no inhibition of platelet function
- since anti-inflammatory properties are due to COX-2 inhibition, non- acetylated salicylates are good anti-inflammatory agents
- inhibitor of outer hair cell motility
More General Terms
Additional Terms
- bismuth subsalicylate (Pepto-Bismol, BSS, Kaopectate)
- salicylate in serum/plasma
- salicylate toxicity
Internet Database
References
- Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 853-54, 763
- Clinical Guide to Laboratory Tests, 3rd ed. Teitz ed., W.B. Saunders, 1995
- Department of Veterans Affairs, VA National Formulary
- Medical Knowledge Self Assessment Program (MKSAP) 15, American College of Physicians, Philadelphia 2009
- The Washington Manual of Medical Therapeutics, 33rd edition Foster C et al (eds) Lippincott, Williams & Wilkins, Philadelphia, 2010, pg 945
